CBD Oil Research
CBD Research
For more in-depth resources on CBD and its health benefits, check out some of the leading research for further reading.
Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain
-Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016) | | The Journal of Pain, 17(6), 739-744.
Drug Interactions and CBD Products
-Grayson, L., Vines, B., Nichol, K., & Szaflarski, J. P. (2018). An interaction between warfarin and cannabidiol, a case report. Epilepsy & behavior case reports, 9, 10.
Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain
-Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016) | | The Journal of Pain, 17(6), 739-744.
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
-Ashley C. Bradford and W. David Bradford | 2016;35(7):1230-1236.
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
-Hurd, Y. L., Yoon, M., Manini, A. F., Hernandez, S., Olmedo, R., Ostman, M., & Jutras-Aswad, D. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 807–815. doi:10.1007/s13311-015-0373-7
Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health
-Office of the Surgeon General (2016) U.S. Department of Health and Human Services (HHS), Office of the Surgeon General
The Health Effects of Cannabis and Cannabinoids The Current State of Evidence and Recommendations for Research
-National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. | Washington (DC): National Academies Press (US); 2017 Jan 12.
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies.
-Petzke, F., Enax-Drumova, E. K., & Hauser, W. (2016). Schmerz (Berlin, Germany) | 30(1), 62-88.
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
-Piper, B.J., DeKeuster, R.M., Beals, M.L., Cobb, C.M., Burchman, C.A., Perkinson, L., Abess, A.T. (2017). | Journal of Psychopharmacology, 31(5), 569-575.
Clinicians’ Guide to Cannabidiol and Hemp Oils. Mayo Clinic Proceedings
-VanDolah, Harrison J. et al. | Volume 94, Issue 9, 1840 – 1851.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
-Whiting PF, Wolff RF, Deshpande S, et al. | JAMA. 2015;313(24):2456–2473.